Kathryn E. Stein

2.2k total citations
33 papers, 1.7k citations indexed

About

Kathryn E. Stein is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Kathryn E. Stein has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Immunology. Recurrent topics in Kathryn E. Stein's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Glycosylation and Glycoproteins Research (5 papers) and Bacterial Infections and Vaccines (5 papers). Kathryn E. Stein is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Glycosylation and Glycoproteins Research (5 papers) and Bacterial Infections and Vaccines (5 papers). Kathryn E. Stein collaborates with scholars based in United States, Sweden and Canada. Kathryn E. Stein's co-authors include Gopi Shankar, Charles Pendley, Syd Johnson, Scott Koenig, Ezio Bonvini, Donald M. Marcus, Kurt Brorson, Elizabeth Hamilton, Johnny Ludvigsson and Nicole Sherry and has published in prestigious journals such as The Lancet, Nature Biotechnology and The Journal of Immunology.

In The Last Decade

Kathryn E. Stein

33 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn E. Stein United States 20 578 572 562 467 400 33 1.7k
Wouter L. W. Hazenbos Netherlands 17 701 1.2× 148 0.3× 368 0.7× 481 1.0× 98 0.2× 26 1.3k
C.L. Cambiaso Belgium 23 691 1.2× 155 0.3× 590 1.0× 449 1.0× 83 0.2× 65 1.8k
A. Termijtelen Netherlands 24 1.7k 3.0× 281 0.5× 445 0.8× 499 1.1× 163 0.4× 65 2.3k
Jiří Kovařík Switzerland 23 802 1.4× 157 0.3× 290 0.5× 95 0.2× 189 0.5× 53 1.7k
R. Grubb Sweden 21 565 1.0× 250 0.4× 465 0.8× 473 1.0× 79 0.2× 69 1.9k
A. Di Carlo Italy 22 187 0.3× 85 0.1× 238 0.4× 120 0.3× 179 0.4× 85 1.3k
Dale Christiansen Australia 21 420 0.7× 320 0.6× 304 0.5× 113 0.2× 430 1.1× 53 1.3k
Edmund J. Gosselin United States 21 1.0k 1.8× 176 0.3× 683 1.2× 456 1.0× 104 0.3× 51 1.9k
Marcella Sarzotti United States 19 1.1k 1.9× 242 0.4× 453 0.8× 97 0.2× 117 0.3× 39 1.8k
Xavier Paliard United States 22 1.7k 2.9× 214 0.4× 360 0.6× 372 0.8× 79 0.2× 33 2.6k

Countries citing papers authored by Kathryn E. Stein

Since Specialization
Citations

This map shows the geographic impact of Kathryn E. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn E. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn E. Stein more than expected).

Fields of papers citing papers by Kathryn E. Stein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn E. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn E. Stein. The network helps show where Kathryn E. Stein may publish in the future.

Co-authorship network of co-authors of Kathryn E. Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn E. Stein. A scholar is included among the top collaborators of Kathryn E. Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn E. Stein. Kathryn E. Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Muessig, Kathryn E., A. T. Panter, Kathryn E. Stein, et al.. (2015). Medication-Taking Practices of Patients on Antiretroviral HIV Therapy: Control, Power, and Intentionality. AIDS Patient Care and STDs. 29(11). 606–616. 17 indexed citations
3.
Grewe, Mary E., Alexis C. Dennis, Elizabeth Chen, et al.. (2015). ‘I learned to accept every part of myself’: the transformative impact of a theatre-based sexual health and HIV prevention programme. Sex Education. 15(3). 303–317. 12 indexed citations
4.
Hagopian, William, Robert J. Ferry, Nicole Sherry, et al.. (2013). Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes. Diabetes. 62(11). 3901–3908. 173 indexed citations
5.
Sherry, Nicole, William Hagopian, Johnny Ludvigsson, et al.. (2011). Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial. The Lancet. 378(9790). 487–497. 363 indexed citations
6.
MacLachlan, Timothy K., Nadine Tuaillon, Syd Johnson, et al.. (2011). Nonclinical Evaluation of GMA161—An Antihuman CD16 (FcγRIII) Monoclonal Antibody for Treatment of Autoimmune Disorders in CD16 Transgenic Mice. Toxicological Sciences. 125(1). 299–309. 26 indexed citations
7.
8.
Kozlowski, Steven, et al.. (2004). Surface Plasmon Resonance Analysis of Antipolysaccharide Antibody Specificity: Responses to Meningococcal Group C Conjugate Vaccines and Bacteria. Infection and Immunity. 72(6). 3451–3460. 15 indexed citations
9.
Muthukkumar, Subramanian & Kathryn E. Stein. (2003). Immunization with meningococcal polysaccharide–tetanus toxoid conjugate induces polysaccharide-reactive T cells in mice. Vaccine. 22(9-10). 1290–1299. 15 indexed citations
10.
Brorson, Kurt, et al.. (2003). Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins. Biotechnology and Bioengineering. 82(3). 321–329. 102 indexed citations
11.
Brorson, Kurt, Janice Brown, Elizabeth Hamilton, & Kathryn E. Stein. (2003). Identification of protein A media performance attributes that can be monitored as surrogates for retrovirus clearance during extended re-use. Journal of Chromatography A. 989(1). 155–163. 59 indexed citations
12.
Brorson, Kurt, Yuan Xu, Patrick G. Swann, et al.. (2002). Evaluation of a Quantitative Product-enhanced Reverse Transcriptase Assay to Monitor Retrovirus in mAb Cell-culture. Biologicals. 30(1). 15–26. 25 indexed citations
13.
Brorson, Kurt, Elizabeth Hamilton, Patrick G. Swann, et al.. (2002). Impact of cell culture process changes on endogenous retrovirus expression. Biotechnology and Bioengineering. 80(3). 257–267. 23 indexed citations
14.
Stein, Kathryn E. & Keith O. Webber. (2001). The regulation of biologic products derived from bioengineered plants. Current Opinion in Biotechnology. 12(3). 308–311. 20 indexed citations
15.
Muthukkumar, Subramanian, Julia Goldstein, & Kathryn E. Stein. (2000). The Ability of B Cells and Dendritic Cells to Present Antigen Increases During Ontogeny. The Journal of Immunology. 165(9). 4803–4813. 73 indexed citations
16.
Brorson, Kurt, et al.. (1999). Mutational Analysis of Avidity and Fine Specificity of Anti-Levan Antibodies. The Journal of Immunology. 163(12). 6694–6701. 9 indexed citations
17.
Stein, Kathryn E.. (1997). Overcoming obstacles to monoclonal antibody product development and approval. Trends in biotechnology. 15(3). 88–90. 11 indexed citations
18.
Brorson, Kurt, et al.. (1995). Immunoglobulin isotype switching in xid mice. Molecular Immunology. 32(7). 487–494. 6 indexed citations
19.
Stein, Kathryn E., Colette Kanellopoulos‐Langevin, David I. Cohen, & John K. Inman. (1980). A quick method for the preparation of stable DNP red cell conjugates. Journal of Immunological Methods. 37(1). 83–88. 9 indexed citations
20.
Bona, Constantin A., James J. Mond, Kathryn E. Stein, et al.. (1979). Immune response to levan. III. The capacity to produce anti-inulin antibodies and cross-reactive idiotypes appears late in ontogeny.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 123(4). 1484–90. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wouter L. W. Hazenbos Breakdown of academic impact, for papers by C.L. Cambiaso Breakdown of academic impact, for papers by A. Termijtelen Breakdown of academic impact, for papers by Jiří Kovařík Breakdown of academic impact, for papers by R. Grubb Breakdown of academic impact, for papers by A. Di Carlo Breakdown of academic impact, for papers by Dale Christiansen Breakdown of academic impact, for papers by Edmund J. Gosselin Breakdown of academic impact, for papers by Marcella Sarzotti Breakdown of academic impact, for papers by Xavier Paliard
Rankless by CCL
2026